Quimatryx
SECTOR: Health, Pharmaceuticals and Biotechnology
Registered Global Reach
China
History of International Operations
| Date | Operation Summary | Key Figures / Investment | Destination Country |
|---|---|---|---|
| 2022-04-04 |
The Gipuzkoa-based company Quimatryx has licensed a cancer drug to the Chinese company HiDiamond. HiDiamond will conduct the regulatory preclinical phase and clinical trials in China, with payments tied to development milestones and sales.
|
92 million | China |





